← All diseases
Liver, kidneys and digestion
Primary sclerosing cholangitis
Would you like to receive a message when there is new research on Primary sclerosing cholangitis? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above every publication you'll see one sentence explaining what was investigated — and you'll get notified as soon as there is new research on Primary sclerosing cholangitis. View what Premium costs.
Publications and studies (1451)
- Commentary or editorialiAn expert's opinion or commentary, not new research. Transplantation for unresectable perihilar cholangiocarcinoma beyond the Mayo protocol: a challenge for SURE. (2026/06/01) ♡
- Utilizing the novel peroral choledochoscope for the treatment of hepatolithiasis about primary sclerosing cholangitis. (2026/06/01) ♡
- Is it time to consider oral vancomycin treatment for the management of pediatric inflammatory bowel disease irrespective of the presence of primary sclerosing cholangitis? (2026/06/01) ♡
- Single-cell transcriptomics reveals the ameliorative effect of gastrodin on cholestatic liver fibrosis. (2026/06/01) ♡
- Longitudinal health-related quality of life and associated factors in autoimmune liver diseases. (2026/06/01) ♡
- Homeostasis of Molybdenum, Xanthine Oxidase and Aldehyde Oxidase Activity Levels in the Livers of Patients with End-Stage Liver Failure and Healthy Controls. (2026/05/31) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Brewing an Interaction: Non-commercial Green Tea-Associated Supratherapeutic Tacrolimus Levels Presenting With Gastrointestinal Symptoms. (2026/05/30) ♡
- Structural and functional hepatic factors as prognostic indicators in children with Langerhans cell histiocytosis. (2026/05/29) ♡
- A Dual-Gene Signature of PMAIP1 and GADD45A for Early Detection of Intrahepatic Cholangiocarcinoma in the Context of Primary Sclerosing Cholangitis. (2026/05/27) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Long-term MAPK inhibition of childhood refractory-Langerhans cell histiocytosis: an observational study of 288 patients. (2026/05/26) ♡
- Cholangiocyte RUNX1 Orchestrates Fibrogenic and Inflammatory Signaling to Drive Biliary Fibrosis. (2026/05/22) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Overlap Syndrome Between Autoimmune Hepatitis and Primary Sclerosing Cholangitis in a Seven-Year-Old Child: A Case Report. (2026/05/21) ♡
- Efficacy, safety, and relapse outcomes of MAPK inhibitors in pediatric Langerhans cell histiocytosis: A real-world study. (2026/05/15) ♡
- A Time-Dependent Prognostic Score (Helsinki Primary Sclerosing Cholangitis Score) to Predict Disease Outcomes in Primary Sclerosing Cholangitis. (2026/05/12) ♡
- Expression characteristics of C-reactive protein in autoimmune diseases and their complications. (2026/05/11) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Safety and Efficacy of Upadacitinib in Patients with Inflammatory Bowel Disease After Liver Transplantation: A Case Series. (2026/05/01) ♡
- Risk of Intestinal and Extraintestinal Malignancies in Inflammatory Bowel Disease With and Without Primary Sclerosing Cholangitis. (2026/05/01) ♡
- A multilevel analysis of the genetic association between inflammatory bowel disease and primary sclerosing cholangitis. (2026/05/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Differences in immunosuppressive strategies for primary sclerosing cholangitis after liver transplantation. (2026/05/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Successful Anesthetic Management of Deceased Donor Liver Transplant in a Patient With Neonatal Sclerosing Cholangitis As a Result of DCDC2 (doublecortin domain-containing protein 2) Mutation: A Case Report. (2026/05/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Patient-reported Symptoms Are Independent of Extent of Disease in Longstanding Ulcerative Colitis: Magic in Imagine. (2026/05/01) ♡
- Pediatric MR cholangiopancreatography: comparison of 3D fast spin-echo and single-shot fast spin-echo thick-slab techniques for pancreaticobiliary anatomy. (2026/04/30) ♡
- Accurate detection of cholangiocarcinoma in primary sclerosing cholangitis using DNA methylation biomarkers in bile and plasma. (2026/04/29) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Successful Treatment of Refractory Pruritus in Primary Sclerosing Cholangitis with Upadacitinib: A Case Report. (2026/04/27) ♡
- Macrophage signaling associates with fibrogenic program activation in periductal fibroblasts in pediatric primary sclerosing cholangitis. (2026/04/23) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Primary sclerosing cholangitis. (2026/04/18) ♡
- Co-creating discovery in basic science: Challenges and opportunities in patient-partnered research for rare liver disease. (2026/04/16) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Organising pneumonia in ulcerative colitis with primary sclerosing cholangitis: drug-related toxicity or extraintestinal manifestation? (2026/04/07) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Clinicopathological features of hepatic Langerhans cell histiocytosis: report of ten cases and review of the literature. (2026/04/01) ♡
- A Pharmacovigilance Study of Immune Checkpoint Inhibitor-Associated Cholangitis: Insights From the FDA Adverse Event Reporting System. (2026/04/01) ♡
- Geography-independent mucosal microbiota alterations in primary sclerosing cholangitis persist after liver transplantation. (2026/04/01) ♡
- Treatment guidelineiAn official agreement between doctors about how this disease should be treated. This is not a single study but the conclusion of an entire medical field. Spanish clinical practice guidelines for the diagnosis and management of cholestatic liver diseases in adult and pediatric population: Joint report from AEEH and SEGHNP. (2026/04/01) ♡
- Moderate increase of MET in hepatocytes protects against cholestatic liver injury by promoting an effective antioxidant response. (2026/04/01) ♡
- Risk of Incident Immune-Mediated Inflammatory Diseases with Second Tumor Necrosis Factor Inhibitor Versus Alternative Biologic Therapy in Patients with Inflammatory Bowel Disease and First TNFi Exposure: A Real-World Cohort Study. (2026/04/01) ♡
- Bile Acid Sequestrants in Primary Sclerosing Cholangitis and the Risk of Acute Cholangitis: Cause for Concern? (2026/04/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Graft and Patient Survival After Liver Transplantation for Primary Sclerosing Cholangitis: A French National Cohort Study. (2026/04/01) ♡
- Defining the Contribution of Genetic Variants in MRGPRX4 With Pruritus in Paediatric Cholestasis: Evidence From Case-Control Study. (2026/04/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. [Hepatic Overlap Syndrome: Primary Sclerosing Cholangitis and Primary Biliary Cholangitis. Case Review]. (2026/04/01) ♡
- Gallbladder neoplasia is associated with a higher incidence of cholangiocarcinoma in patients with primary sclerosing cholangitis. (2026/03/31) ♡
- Incidence and prevalence of immune-mediated extraintestinal manifestations in pediatric inflammatory bowel disease: a systematic review and meta-analysis. (2026/03/31) ♡
- Endoscopic management of biliary stricture in primary sclerosing cholangitis. (2026/03/25) ♡
- miR-21-5p dysregulation is associated with gut microbiota dysbiosis and pro-oncogenic markers in primary sclerosing cholangitis with concomitant inflammatory bowel disease. (2026/03/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A rare case of IgG4-related sclerosing cholangitis followed by rapid subsequent diagnosis of cholangiocarcinoma. (2026/03/01) ♡
- Clinical, Endoscopic, and Upper Gastrointestinal Histological Manifestations in Pediatric Inflammatory Bowel Disease: Insights from a Large Cohort. (2026/03/01) ♡
- Primary sclerosing cholangitis pathogenesis revisited: EBV-idence of immune dysregulation. (2026/03/01) ♡
- Hepatocyte Mettl3 Deficiency Drives Primary Sclerosing Cholangitis and Liver Fibrosis via Cholangiocyte-Macrophage Crosstalk. (2026/03/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Quality of Life in Patients With Variant Syndromes of Autoimmune Liver Diseases-A Cross-Sectional Multicentre Study. (2026/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Oral vancomycin for primary sclerosing cholangitis and associated inflammatory bowel disease - paving a path forward. (2026/03/01) ♡
- Incidence and Risk of Colorectal Dysplasia in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study. (2026/02/16) ♡
- Novel MicroRNA biomarkers revealed in the serum and bile of thioacetamide induced cholangiocarcinoma. (2026/02/11) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.